Universal Biosensors
(ASX:UBI) is a medical diagnostics company. We are targeting a segment of the diagnostics landscape called the point of care diagnostics market, a $15 billion global market that's growing quite rapidly.
We're exploiting a valuable and unique diagnostics platform technology, it's patented by about 500 patents and protected by trade secrets. That allows us to look for bio-markers in a tiny drop of blood.
We believe we have validated that technology and our company's capabilies by partnering with and developing products for Johnston & Johnston's life-scan division - a specialist in diabetes.
